NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-35 Cr | ₹-27 Cr | ₹-27 Cr | ₹-14 Cr | ₹-25 Cr |
What is the latest Cash Flow from Investing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-35 Cr |
Mar2024 | ₹-27 Cr |
Mar2023 | ₹-27 Cr |
Mar2022 | ₹-14 Cr |
Mar2021 | ₹-25 Cr |
How is Cash Flow from Investing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-35 Cr | Negative | |
Mar2024 | ₹-27 Cr | Negative | |
Mar2023 | ₹-27 Cr | Negative | |
Mar2022 | ₹-14 Cr | Negative | |
Mar2021 | ₹-25 Cr | - |
Compare Cash Flow from Investing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹880.8 Cr | -5.4% | 16.7% | -34.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -5.4% |
16.7% |
-34.8% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses